QL
SNDX icon

Quarry LP’s Syndax Pharmaceuticals SNDX Stock Holding History

Quarry LP’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22 Buy
+1
New +$21 ﹤0.01% 2367
2026
Q1 		– Sell
-10,000
Closed -$210K – 2181
2025
Q4 		$210K Sell
10,000
-25,365
-72% -$443K 0.03% 264
2025
Q3 		$544K Sell
35,365
-23,635
-40% -$309K 0.12% 132
2025
Q2 		$553K Buy
59,000
+57,000
+2,850% +$627K 0.12% 141
2025
Q1 		$24.6K Buy
+2,000
New +$28.2K 0.01% 1061
2024
Q3 		– Sell
-6,125
Closed -$126K – 2049
2024
Q2 		$126K Buy
6,125
+2,625
+75% +$54.9K 0.04% 275
2024
Q1 		$83.3K Buy
3,500
+2,750
+367% +$61.3K 0.02% 275
2023
Q4 		$16.2K Buy
+750
New +$11.5K ﹤0.01% 868

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Quarry LP's SNDX Position: Q2 2026 in Review

Quarry LP opened a new position in Syndax Pharmaceuticals (SNDX) in Q2 2026: 1 share worth $22. The stake represents ﹤0.01% of the portfolio and ranks #2367 among its holdings. This is a return to the name: Quarry LP previously reported a position in SNDX as recently as Q4 2025.

Quarry LP first reported a position in SNDX in Q4 2023 and has held it in 8 quarters since. The position peaked at $553K in Q2 2025. 243 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Quarry LP held 1 share of Syndax Pharmaceuticals worth $22 as of Q2 2026.
  • Syndax Pharmaceuticals was a new Quarry LP position in Q2 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #2367 holding.
  • Quarry LP first reported a position in Syndax Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
  • Quarry LP's Syndax Pharmaceuticals position peaked at $553K in Q2 2025.
  • 243 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.